Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Perceptive Advisors
company
Investments
Number of Investments
Number of Lead Investments
44
19
Perceptive Advisors has made 44 investments. Their most recent investment was on
Dec 7, 2022, when Apogee Therapeutics, Inc raised
| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Dec 7, 2022 | Apogee Therapeutics | Series B | — | Biotechnology | — |
| Nov 16, 2022 | Biodesix | Post-IPO Debt | — | Biotechnology | Yes |
| Apr 12, 2022 | Surf Bio | Seed | — | Biotechnology | Yes |
| Mar 8, 2022 | DNAnexus | Series H | — | Bioinformatics | — |
| Dec 7, 2021 | Freenome | Series D | — | Biotechnology | Yes |
| Oct 7, 2021 | Science 37 | Post-IPO Equity | — | Biotechnology | — |
| Sep 7, 2021 | Emulate | Series E | — | Biotechnology | — |
| Sep 1, 2021 | SomaLogic | Post-IPO Equity | — | Biotechnology | — |
| Aug 19, 2021 | Bridge to Life Ltd. | Series Unknown | — | Biotechnology | Yes |
| Jun 25, 2021 | Kindbody | Series C | — | Employee Benefits | — |
| May 13, 2021 | Cue | Series Unknown | — | Health Care | — |
| May 12, 2021 | Juno Diagnostics | Series A | — | Biotechnology | Yes |
| Apr 29, 2021 | Forge Biologics | Series B | — | Biotechnology | — |
| Mar 31, 2021 | Scribe Therapeutics | Series B | — | Biotechnology | — |
| Mar 23, 2021 | Absci | Series Unknown | — | Artificial Intelligence | — |
| Jan 27, 2021 | DarioHealth | Post-IPO Equity | — | Health Care | — |
| Jan 19, 2021 | Beam Therapeutics | Post-IPO Equity | — | Biotechnology | — |
| Jan 7, 2021 | IsoPlexis | Debt Financing | — | Biotechnology | Yes |
| Jan 7, 2021 | IsoPlexis | Series D | — | Biotechnology | Yes |
| Nov 9, 2020 | Prometheus Biosciences | Private Equity（PE） | — | Biotechnology | — |
| Sep 22, 2020 | Willow | Series C | — | Child Care | Yes |
| Aug 26, 2020 | Freenome | Series C | — | Biotechnology | Yes |
| Jul 21, 2020 | Forge Biologics | Series A | — | Biotechnology | Yes |
| Jul 8, 2020 | Kindbody | Series B | — | Employee Benefits | Yes |
| Jun 9, 2020 | DNAnexus | Series G | — | Bioinformatics | Yes |
| Dec 5, 2019 | Black Diamond Therapeutics | Series C | — | Biotechnology | — |
| Nov 13, 2019 | Avidity Biosciences | Series C | — | Biotechnology | — |
| Jul 24, 2019 | Freenome | Series B | — | Biotechnology | — |
| May 6, 2019 | Athenex | Post-IPO Equity | — | Biotechnology | — |
| Apr 16, 2019 | Kindbody | Series A | — | Employee Benefits | Yes |
| Mar 25, 2019 | Saama | Series Unknown | — | Analytics | — |
| Feb 12, 2019 | ADMA Biologics | Post-IPO Debt | — | Biotechnology | Yes |
| Jan 9, 2019 | Black Diamond Therapeutics | Series B | — | Biotechnology | — |
| Jul 2, 2018 | Athenex | Post-IPO Equity | — | Biotechnology | Yes |
| May 18, 2017 | Xontogeny | Series A | — | Biopharma | Yes |
| May 16, 2017 | Synlogic | Series C | — | Biotechnology | — |
| Dec 1, 2016 | Motus GI | Series Unknown | — | Biotechnology | Yes |
| Jul 18, 2016 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
| Jun 2, 2016 | VitalConnect | Series B | — | Biotechnology | Yes |
| Jan 8, 2016 | Zymeworks | Series A | — | Biotechnology | — |
| Sep 29, 2015 | Outlook Therapeutics | Series Unknown | — | Biopharma | — |
| Jul 27, 2015 | Outlook Therapeutics | Series Unknown | — | Biopharma | Yes |
| Nov 12, 2014 | Blueprint Medicines | Series C | — | Bioinformatics | — |
| Oct 13, 2014 | Invitae | Series F | — | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
